Erratum: Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
Authors:
Published: 2023-04-27
DOI:
10.1200/jco.23.00658
Source:
Full article
Abstract
No abstract found.